ROC analysis investigating the capability of these cytokines/chemokines to differentiate cerebral involvement in X-ALD patients showed that none of these biomarkers further improved the ability of NfL to discriminate the onset of CALD in X-ALD children (Supplementary Table S3). This evidence concerns the gene NEFL and X-linked adrenoleukodystrophy.